Chongqing Lummy Pharmaceutical Co.,Ltd
As of 17 November 2026, for the company name Chongqing Lummy Pharmaceutical Co.,Ltd as recorded, 12 applications with this name as first applicant are listed as under review at China's CDE; the CDE acceptance records name it as first applicant on 56 records, across 36 drug names; since 21 August 2026, the records list Accepted: 1 application, No longer listed under review: 1 application; the chemical-drug catalogue lists 32 active records with this name as holder; 3 active API registrations list this name as first registered company; 7 further acceptance records name it after the first applicant.
Check drug filings and source records for this company-name string.
Listed by the company name as recorded in the source, without merging affiliated entities.
Page reference
These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/17.
Drug filings
56 acceptance records as first applicant, grouped into 36 source drug names. Source data as of 2026/11/17.
Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.
Edaravone and Dexborneol Concentrated Solution for Injection 1 records · Latest accepted 2026/09/29
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2602424 | Generic | 2026/09/29 | Chongqing Lummy Pharmaceutical Co.,Ltd | CDE ↗ |
注射用尼麦角林 · No verified English name 1 records · Latest accepted 2026/08/18
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2601565 | Supplement | 2026/08/18 | Chongqing Lummy Pharmaceutical Co.,Ltd | CDE ↗ |
Omeprazole Sodium for Injection 1 records · Latest accepted 2026/06/30
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2601221 | Supplement | 2026/06/30 | Chongqing Lummy Pharmaceutical Co.,Ltd | CDE ↗ |
Nafamostat Mesilate for Injection 1 records · Latest accepted 2026/06/25
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2601499 | Generic | 2026/06/25 | Chongqing Lummy Pharmaceutical Co.,Ltd | CDE ↗ |
Sivelestat Sodium for Injection 1 records · Latest accepted 2026/06/05
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2601320 | Generic | 2026/06/05 | Chongqing Lummy Pharmaceutical Co.,Ltd | CDE ↗ |
Vitamin K1 Injection 1 records · Latest accepted 2026/05/12
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2601084 | Generic | 2026/05/12 | Chongqing Lummy Pharmaceutical Co.,Ltd; Nanjing Chen Gong Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Baloxavir Marboxil Tablets 1 records · Latest accepted 2025/12/25
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2504401 | Generic | 2025/12/25 | Chongqing Lummy Pharmaceutical Co.,Ltd; Chongqing Bo Teng Pharma Co., Ltd. romanized | CDE ↗ |
西诺氨酯片 · No verified English name 3 records · Latest accepted 2025/12/24
Generic · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2504376 | Generic | 2025/12/24 | Chongqing Lummy Pharmaceutical Co.,Ltd | CDE ↗ |
| CYHS2504375 | Generic | 2025/12/24 | Chongqing Lummy Pharmaceutical Co.,Ltd | CDE ↗ |
| CYHS2504374 | Generic | 2025/12/24 | Chongqing Lummy Pharmaceutical Co.,Ltd | CDE ↗ |
Pemetrexed Disodium for Injection 2 records · Latest accepted 2025/11/20
Supplement · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2502378 | Supplement | 2025/11/20 | Chongqing Lummy Pharmaceutical Co.,Ltd; Hebei Dao En Pharma Co., Ltd. romanized | CDE ↗ |
| CYHB2502377 | Supplement | 2025/11/20 | Chongqing Lummy Pharmaceutical Co.,Ltd; Hebei Dao En Pharma Co., Ltd. romanized | CDE ↗ |
Loxoprofen Sodium Patches 2 records · Latest accepted 2025/09/10
Generic · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2503350 | Generic | 2025/09/10 | Chongqing Lummy Pharmaceutical Co.,Ltd; Nanjing Jiu Xiao Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2503349 | Generic | 2025/09/10 | Chongqing Lummy Pharmaceutical Co.,Ltd; Nanjing Jiu Xiao Pharma Co., Ltd. romanized | CDE ↗ |
Finerenone Tablets 1 records · Latest accepted 2025/08/12
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2502931 | Generic | 2025/08/12 | Chongqing Lummy Pharmaceutical Co.,Ltd | CDE ↗ |
Methylprednisolone Sodium Succinate for injection 1 records · Latest accepted 2025/08/08
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2501569 | Supplement | 2025/08/08 | Chongqing Lummy Pharmaceutical Co.,Ltd | CDE ↗ |
Naloxone Hydrochloride Injection 3 records · Latest accepted 2025/02/20
Supplement · 2Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2500345 | Supplement | 2025/02/20 | Chongqing Lummy Pharmaceutical Co.,Ltd | CDE ↗ |
| CYHB2500343 | Supplement | 2025/02/20 | Chongqing Lummy Pharmaceutical Co.,Ltd | CDE ↗ |
| CYHS2202015 | Generic | 2022/11/18 | Chongqing Lummy Pharmaceutical Co.,Ltd | CDE ↗ |
Aztreonam For Injection 2 records · Latest accepted 2025/02/08
Supplement · 2
Acetylcysteine Solution For Inhalation 1 records · Latest accepted 2025/01/15
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2500291 | Generic | 2025/01/15 | Chongqing Lummy Pharmaceutical Co.,Ltd | CDE ↗ |
头孢泊肟酯干混悬剂 · No verified English name 1 records · Latest accepted 2024/08/27
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2401333 | Supplement | 2024/08/27 | Chongqing Lummy Pharmaceutical Co.,Ltd; Chongqing Ke Rui Pharmaceutical (Group) Co., Ltd. romanized | CDE ↗ |
Nicorandil Tablets 1 records · Latest accepted 2024/06/07
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2401714 | Generic | 2024/06/07 | Chongqing Lummy Pharmaceutical Co.,Ltd | CDE ↗ |
阿奇霉素颗粒 · No verified English name 1 records · Latest accepted 2024/01/13
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2400199 | Generic | 2024/01/13 | Chongqing Lummy Pharmaceutical Co.,Ltd | CDE ↗ |
Mycophenolate Mofetil for Injection 1 records · Latest accepted 2024/01/09
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2450023 | Supplement | 2024/01/09 | Chongqing Lummy Pharmaceutical Co.,Ltd | CDE ↗ |
Clindamycin Injection 2 records · Latest accepted 2023/12/30
Supplement · 2
Ketorolac Tromethamine Injection 2 records · Latest accepted 2023/12/22
Generic · 2
Esomeprazole Magnesium Enteric-Coated Capsules 4 records · Latest accepted 2023/09/12
Supplement · 2Generic · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2302058 | Supplement | 2023/09/12 | Chongqing Lummy Pharmaceutical Co.,Ltd | CDE ↗ |
| CYHB2302057 | Supplement | 2023/09/12 | Chongqing Lummy Pharmaceutical Co.,Ltd | CDE ↗ |
| CYHS2100264 | Generic | 2021/03/09 | Chongqing Lummy Pharmaceutical Co.,Ltd | CDE ↗ |
| CYHS2100263 | Generic | 2021/03/09 | Chongqing Lummy Pharmaceutical Co.,Ltd | CDE ↗ |
Alanyl Glutamine Injection 2 records · Latest accepted 2023/09/06
Supplement · 2
Nicorandil for Injection 4 records · Latest accepted 2023/08/23
Generic · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2302248 | Generic | 2023/08/23 | Chongqing Lummy Pharmaceutical Co.,Ltd | CDE ↗ |
| CYHS2302247 | Generic | 2023/08/23 | Chongqing Lummy Pharmaceutical Co.,Ltd | CDE ↗ |
| CYHS2301394 | Generic | 2023/05/23 | Chongqing Lummy Pharmaceutical Co.,Ltd | CDE ↗ |
| CYHS2301393 | Generic | 2023/05/23 | Chongqing Lummy Pharmaceutical Co.,Ltd | CDE ↗ |
Nimodipine Injection 1 records · Latest accepted 2023/07/21
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2301948 | Generic | 2023/07/21 | Chongqing Lummy Pharmaceutical Co.,Ltd | CDE ↗ |
Tranexamic Acid and Sodium Chloride Injection 1 records · Latest accepted 2023/07/14
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2350566 | Supplement | 2023/07/14 | Chongqing Lummy Pharmaceutical Co.,Ltd | CDE ↗ |
Esomeprazole Sodium for Injection 2 records · Latest accepted 2023/04/20
Supplement · 2
奥美拉唑镁肠溶片 · No verified English name 1 records · Latest accepted 2023/01/13
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2300131 | Generic | 2023/01/13 | Chongqing Lummy Pharmaceutical Co.,Ltd | CDE ↗ |
Triptorelin Acetate Injection 1 records · Latest accepted 2022/11/16
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2202106 | Supplement | 2022/11/16 | Chongqing Lummy Pharmaceutical Co.,Ltd; Hainan Shuang Cheng Pharma Co., Ltd. romanized | CDE ↗ |
Telmisartan Tablets 2 records · Latest accepted 2022/10/14
Supplement · 2
纳米炭混悬注射液 · No verified English name 2 records · Latest accepted 2022/06/14
Supplement · 2
Terlipressin for Injection 1 records · Latest accepted 2022/04/15
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2200596 | Generic | 2022/04/15 | Chongqing Lummy Pharmaceutical Co.,Ltd | CDE ↗ |
Ramosetron Hydrochloride Injection 1 records · Latest accepted 2022/04/13
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2250214 | Supplement | 2022/04/13 | Chongqing Lummy Pharmaceutical Co.,Ltd | CDE ↗ |
Paclitaxel Injection 1 records · Latest accepted 2022/03/29
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2250190 | Supplement | 2022/03/29 | Chongqing Lummy Pharmaceutical Co.,Ltd | CDE ↗ |
Tranexamic Acid Injection 2 records · Latest accepted 2021/11/03
Supplement · 2
Fludarabine Phosphate For Injection 1 records · Latest accepted 2021/09/29
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2150893 | Supplement | 2021/09/29 | Chongqing Lummy Pharmaceutical Co.,Ltd | CDE ↗ |
Changes in the last 90 days
2 events from 2026/08/21 to 2026/11/18. CDE data as of 2026/11/17; NMPA data as of 2026/11/17.
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Accepted: 1 applicationNo longer listed under review: 1 application
- 2026/11/17No longer listed under review
西诺氨酯片 · No verified English name
CYHS2504376
Fact date: 2026/11/17 · Date added to this site: 2026/11/17
Accepted: 2025/12/24
no longer on the CDE under-review list as of the data cut-off; the review / approval outcome is to be checked
View source ↗ - 2026/09/29Accepted
Edaravone and Dexborneol Concentrated Solution for Injection
CYHS2602424
Fact date: 2026/09/29 · Date added to this site: 2026/10/22
View source ↗
Under review
12 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/17.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| Edaravone and Dexborneol Concentrated Solution for Injection | CYHS2602424 | Generic | 2026/09/29 | Chongqing Lummy Pharmaceutical Co.,Ltd | CDE ↗ |
| 注射用尼麦角林 · No verified English name | CYHB2601565 | Supplement | 2026/08/18 | Chongqing Lummy Pharmaceutical Co.,Ltd | CDE ↗ |
| Nafamostat Mesilate for Injection | CYHS2601499 | Generic | 2026/06/25 | Chongqing Lummy Pharmaceutical Co.,Ltd | CDE ↗ |
| Sivelestat Sodium for Injection | CYHS2601320 | Generic | 2026/06/05 | Chongqing Lummy Pharmaceutical Co.,Ltd | CDE ↗ |
| Vitamin K1 Injection | CYHS2601084 | Generic | 2026/05/12 | Chongqing Lummy Pharmaceutical Co.,Ltd; Nanjing Chen Gong Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| Baloxavir Marboxil Tablets | CYHS2504401 | Generic | 2025/12/25 | Chongqing Lummy Pharmaceutical Co.,Ltd; Chongqing Bo Teng Pharma Co., Ltd. romanized | CDE ↗ |
| 西诺氨酯片 · No verified English name | CYHS2504375 | Generic | 2025/12/24 | Chongqing Lummy Pharmaceutical Co.,Ltd | CDE ↗ |
| 西诺氨酯片 · No verified English name | CYHS2504374 | Generic | 2025/12/24 | Chongqing Lummy Pharmaceutical Co.,Ltd | CDE ↗ |
| Loxoprofen Sodium Patches | CYHS2503350 | Generic | 2025/09/10 | Chongqing Lummy Pharmaceutical Co.,Ltd; Nanjing Jiu Xiao Pharma Co., Ltd. romanized | CDE ↗ |
| Loxoprofen Sodium Patches | CYHS2503349 | Generic | 2025/09/10 | Chongqing Lummy Pharmaceutical Co.,Ltd; Nanjing Jiu Xiao Pharma Co., Ltd. romanized | CDE ↗ |
| Finerenone Tablets | CYHS2502931 | Generic | 2025/08/12 | Chongqing Lummy Pharmaceutical Co.,Ltd | CDE ↗ |
| Methylprednisolone Sodium Succinate for injection | CYHB2501569 | Supplement | 2025/08/08 | Chongqing Lummy Pharmaceutical Co.,Ltd | CDE ↗ |
Catalogue holder records
32 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/17. Manufacturer-only records are excluded.
| Drug | Marketing authorization holder | Manufacturer | Approval number | Approved | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| Aztreonam For Injection | Chongqing Lummy Pharmaceutical Co.,Ltd | Chongqing Lummy Pharmaceutical Co.,Ltd | 国药准字H20123046 | 2026/03/17 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ketorolac Tromethamine Injection | Chongqing Lummy Pharmaceutical Co.,Ltd | Chongqing Lummy Pharmaceutical Co.,Ltd | 国药准字H20255358 | 2025/09/09 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Nicorandil Tablets | Chongqing Lummy Pharmaceutical Co.,Ltd | Chongqing Lummy Pharmaceutical Co.,Ltd | 国药准字H20255452 | 2025/09/09 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Mycophenolate Mofetil for Injection | Chongqing Lummy Pharmaceutical Co.,Ltd | Chongqing Lummy Pharmaceutical Co.,Ltd | 国药准字H20059282 | 2025/07/21 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| 阿奇霉素颗粒 · No verified English name | Chongqing Lummy Pharmaceutical Co.,Ltd | Chongqing Lummy Pharmaceutical Co.,Ltd | 国药准字H20254542 | 2025/06/17 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Naloxone Hydrochloride Injection | Chongqing Lummy Pharmaceutical Co.,Ltd | Chongqing Lummy Pharmaceutical Co.,Ltd | 国药准字H20258070 | 2025/04/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Naloxone Hydrochloride Injection | Chongqing Lummy Pharmaceutical Co.,Ltd | Chongqing Lummy Pharmaceutical Co.,Ltd | 国药准字H20258071 | 2025/04/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Clindamycin Injection | Chongqing Lummy Pharmaceutical Co.,Ltd | Chongqing Lummy Pharmaceutical Co.,Ltd | 国药准字H20043359 | 2025/04/07 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Clindamycin Injection | Chongqing Lummy Pharmaceutical Co.,Ltd | Chongqing Lummy Pharmaceutical Co.,Ltd | 国药准字H20043358 | 2025/04/07 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Nicorandil for Injection | Chongqing Lummy Pharmaceutical Co.,Ltd | Chongqing Lummy Pharmaceutical Co.,Ltd | 国药准字H20253489 | 2025/03/04 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Nicorandil for Injection | Chongqing Lummy Pharmaceutical Co.,Ltd | Chongqing Lummy Pharmaceutical Co.,Ltd | 国药准字H20253490 | 2025/03/04 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Alanyl Glutamine Injection | Chongqing Lummy Pharmaceutical Co.,Ltd | Chongqing Lummy Pharmaceutical Co.,Ltd | 国药准字H20044964 | 2024/11/20 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Alanyl Glutamine Injection | Chongqing Lummy Pharmaceutical Co.,Ltd | Chongqing Lummy Pharmaceutical Co.,Ltd | 国药准字H20044965 | 2024/11/20 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Tranexamic Acid and Sodium Chloride Injection | Chongqing Lummy Pharmaceutical Co.,Ltd | Chongqing Lummy Pharmaceutical Co.,Ltd | 国药准字H20247247 | 2024/10/23 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Nimodipine Injection | Chongqing Lummy Pharmaceutical Co.,Ltd | Chongqing Lummy Pharmaceutical Co.,Ltd | 国药准字H20249173 | 2024/10/22 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Naloxone Hydrochloride Injection | Chongqing Lummy Pharmaceutical Co.,Ltd | Chongqing Lummy Pharmaceutical Co.,Ltd | 国药准字H20243819 | 2024/05/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 奥美拉唑镁肠溶片 · No verified English name | Chongqing Lummy Pharmaceutical Co.,Ltd | Chongqing Lummy Pharmaceutical Co.,Ltd | 国药准字H20243342 | 2024/03/12 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Esomeprazole Sodium for Injection | Chongqing Lummy Pharmaceutical Co.,Ltd | Chongqing Lummy Pharmaceutical Co.,Ltd | 国药准字H20247041 | 2024/03/06 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Terlipressin for Injection | Chongqing Lummy Pharmaceutical Co.,Ltd | Chongqing Lummy Pharmaceutical Co.,Ltd | 国药准字H20234499 | 2023/11/21 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ramosetron Hydrochloride Injection | Chongqing Lummy Pharmaceutical Co.,Ltd | Chongqing Lummy Pharmaceutical Co.,Ltd | 国药准字H20055202 | 2023/11/03 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Telmisartan Tablets | Chongqing Lummy Pharmaceutical Co.,Ltd | Chongqing Lummy Pharmaceutical Co.,Ltd | 国药准字H20237151 | 2023/10/12 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Telmisartan Tablets | Chongqing Lummy Pharmaceutical Co.,Ltd | Chongqing Lummy Pharmaceutical Co.,Ltd | 国药准字H20080222 | 2023/10/12 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Paclitaxel Injection | Chongqing Lummy Pharmaceutical Co.,Ltd | Chongqing Lummy Pharmaceutical Co.,Ltd | 国药准字H20054814 | 2023/06/29 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Fludarabine Phosphate For Injection | Chongqing Lummy Pharmaceutical Co.,Ltd | Chongqing Lummy Pharmaceutical Co.,Ltd | 国药准字H20059418 | 2022/09/06 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Tranexamic Acid Injection | Chongqing Lummy Pharmaceutical Co.,Ltd | Chongqing Lummy Pharmaceutical Co.,Ltd | 国药准字H20056600 | 2022/08/23 | Not stated by source | CDE ↗ |
| Tranexamic Acid Injection | Chongqing Lummy Pharmaceutical Co.,Ltd | Chongqing Lummy Pharmaceutical Co.,Ltd | 国药准字H20056601 | 2022/08/23 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Esomeprazole Magnesium Enteric-Coated Capsules | Chongqing Lummy Pharmaceutical Co.,Ltd | Chongqing Lummy Pharmaceutical Co.,Ltd | 国药准字H20223571 | 2022/08/10 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Esomeprazole Magnesium Enteric-Coated Capsules | Chongqing Lummy Pharmaceutical Co.,Ltd | Chongqing Lummy Pharmaceutical Co.,Ltd | 国药准字H20223570 | 2022/08/10 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Methylprednisolone Sodium Succinate for injection | Chongqing Lummy Pharmaceutical Co.,Ltd | Chongqing Lummy Pharmaceutical Co.,Ltd | 国药准字H20203329 | 2022/01/30 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Voriconazole Tablets | Chongqing Lummy Pharmaceutical Co.,Ltd | Chongqing Lummy Pharmaceutical Co.,Ltd | 国药准字H20213842 | 2021/11/03 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Voriconazole Tablets | Chongqing Lummy Pharmaceutical Co.,Ltd | Chongqing Lummy Pharmaceutical Co.,Ltd | 国药准字H20213841 | 2021/11/03 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Esomeprazole Sodium for Injection | Chongqing Lummy Pharmaceutical Co.,Ltd | Chongqing Lummy Pharmaceutical Co.,Ltd | 国药准字H20203633 | 2020/12/02 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.
API registrations
3 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/17.
| Name | Company / applicant | Registration number | Status | Source update date | View source |
|---|---|---|---|---|---|
| 硫酸氢氯吡格雷 · No verified English name | Chongqing Lummy Pharmaceutical Co.,Ltd | Y20190008177 | A | — | CDE ↗ |
| 甲磺酸伊马替尼 · No verified English name | Chongqing Lummy Pharmaceutical Co.,Ltd | Y20170001106 | I | — | CDE ↗ |
| 盐酸吉西他滨 · No verified English name | Chongqing Lummy Pharmaceutical Co.,Ltd | Y20170000631 | I | — | CDE ↗ |
Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.
Co-applicant records
7 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/17.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| 注射用磷酸左奥硝唑酯二钠 · No verified English name | CYHS2600870 | Generic | 2026/04/16 | Hainan Wei Jian Pharma Co., Ltd. romanized; Chongqing Lummy Pharmaceutical Co.,Ltd | CDE ↗ |
| Hydrocortisone Sodium Succinate for Injection | CYHS2403585 | Generic | 2024/10/24 | Hainan Wei Jian Pharma Co., Ltd. romanized; Chongqing Lummy Pharmaceutical Co.,Ltd | CDE ↗ |
| Hydrocortisone Sodium Succinate for Injection | CYHS2403584 | Generic | 2024/10/24 | Hainan Wei Jian Pharma Co., Ltd. romanized; Chongqing Lummy Pharmaceutical Co.,Ltd | CDE ↗ |
| Hydrocortisone Sodium Succinate for Injection | CYHS2403475 | Generic | 2024/10/15 | Chongqing Wan Lin Biopharmaceuticals Technology Co., Ltd. romanized; Chongqing Lummy Pharmaceutical Co.,Ltd | CDE ↗ |
| Hydrocortisone Sodium Succinate for Injection | CYHS2403474 | Generic | 2024/10/15 | Chongqing Wan Lin Biopharmaceuticals Technology Co., Ltd. romanized; Chongqing Lummy Pharmaceutical Co.,Ltd | CDE ↗ |
| Lornoxicam for Injection | CYHS2400079 | Generic | 2024/01/06 | Chongqing Wan Lin Biopharmaceuticals Technology Co., Ltd. romanized; Chongqing Lummy Pharmaceutical Co.,Ltd | CDE ↗ |
| Lornoxicam for Injection | CYHS2303416 | Generic | 2023/12/09 | Tianjin Mei Hua Biopharmaceuticals Technology Co., Ltd. romanized; Chongqing Lummy Pharmaceutical Co.,Ltd | CDE ↗ |
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/17
- Chemical-drug catalogue
- Last successful update: 2026/11/17
- API registrations
- Last successful update: 2026/11/17
- NMPA drug delivery notices
- Last successful update: 2026/11/17
Loaded notices dated 2026-11-03 to 2026-11-17; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.
Listed by the company name as recorded in the source, without merging affiliated entities.
This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.
Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.